Skip to main content

and
  1. Article

    Open Access

    Single cell characterization of myeloma and its precursor conditions reveals transcriptional signatures of early tumorigenesis

    Multiple myeloma is a plasma cell malignancy almost always preceded by precursor conditions, but low tumor burden of these early stages has hindered the study of their molecular programs through bulk sequencin...

    Rebecca Boiarsky, Nicholas J. Haradhvala, Jean-Baptiste Alberge in Nature Communications (2022)

  2. Article

    Open Access

    Genetic subtypes of smoldering multiple myeloma are associated with distinct pathogenic phenotypes and clinical outcomes

    Smoldering multiple myeloma (SMM) is a precursor condition of multiple myeloma (MM) with significant heterogeneity in disease progression. Existing clinical models of progression risk do not fully capture this...

    Mark Bustoros, Shankara Anand, Romanos Sklavenitis-Pistofidis in Nature Communications (2022)

  3. No Access

    Article

    Single-cell profiling of tumour evolution in multiple myeloma — opportunities for precision medicine

    Multiple myeloma (MM) is a haematological malignancy of plasma cells characterized by substantial intraclonal genetic heterogeneity. Although therapeutic advances made in the past few years have led to improve...

    Ankit K. Dutta, Jean-Baptiste Alberge in Nature Reviews Clinical Oncology (2022)

  4. No Access

    Article

    Inflammatory stromal cells in the myeloma microenvironment

    Single-cell RNA sequencing identifies an inflammatory subpopulation of mesenchymal stromal cells in patients with multiple myeloma.

    Romanos Sklavenitis-Pistofidis, Nicholas J. Haradhvala, Gad Getz in Nature Immunology (2021)

  5. No Access

    Article

    Single-cell RNA sequencing: one step closer to the clinic

    Single-cell RNA-sequencing can help in the prediction of drug resistance in patients with multiple myeloma.

    Romanos Sklavenitis-Pistofidis, Gad Getz, Irene Ghobrial in Nature Medicine (2021)

  6. Article

    Open Access

    Clonal hematopoiesis is associated with adverse outcomes in multiple myeloma patients undergoing transplant

    Multiple myeloma (MM) is a plasma-cell neoplasm that is treated with high-dose chemotherapy, autologous stem cell transplant (ASCT) and long-term immunomodulatory drug (IMiD) maintenance. The presence of somat...

    Tarek H. Mouhieddine, Adam S. Sperling, Robert Redd, Jihye Park in Nature Communications (2020)

  7. No Access

    Article

    Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma

    Precursor states of multiple myeloma (MM) and its native tumor microenvironment need in-depth molecular characterization to better stratify and treat patients at risk. Using single-cell RNA sequencing of bone ...

    Oksana Zavidij, Nicholas J. Haradhvala, Tarek H. Mouhieddine in Nature Cancer (2020)

  8. No Access

    Article

    Acute lymphoblastic leukemia as a clonally unrelated second primary malignancy after multiple myeloma

    Multiple myeloma (MM) patients have an 11-fold increased risk of develo** myeloid neoplasms compared to the general population; however, acute lymphoblastic leukemia (ALL) is rarely observed. Given that both...

    Ibrahim Aldoss, Marzia Capelletti, Jihye Park, Romanos Sklavenitis Pistofidis in Leukemia (2019)

  9. Article

    Primary hyperparathyroidism and the road to surgery: appraisal of the proceedings of the four international workshops (1990, 2002, 2008, 2014) on primary hyperparathyroidism

    Although surgery is unambiguously recommended for symptomatic primary hyperparathyroidism (PHPT) patients, management options for asymptomatic patients have varied between surgery, medications and follow-up. T...

    Romanos Sklavenitis-Pistofidis, Ourania Papaioannou in Hormones (2015)